Oral а-galactosidase in clinical practice


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper evaluates the efficacy and safety of oral а-galactosidase for flatulence and bloating.

Full Text

Restricted Access

About the authors

I. Khlynov

Ural State Medical University

Email: hlinov.doc@yandex.ru

M. Chikunova

Ural State Medical University

Candidate of Medical Sciences

O. Khromtsova

Ural State Medical University

References

  1. Аннотация к БАД Орликс: свидетельство о государственной регистрации RU.77.99.88.003.E.007871.07.15 от 20.07.2015.
  2. Ивашкин В.Т., Драпкина О.М. Пропедевтика внутренних болезней. Гастроэнтерология: учеб. пособие / М.: ГЭОТАР-Медиа, 2012; 160 с.
  3. Accarino A., Perez F., Azpiroz F. et al. Abdominal distention results from caudo-ventral redistribution of contents // Gastroenterology. - 2009; 136: 1544-51.
  4. Azpiroz F., Malagelada J. Abdominal bloating // Gastroenterology. - 2005; 129: 1060-78.
  5. Bengtsson B., Johansson J., Hollak C. et. al. Enzyme replacement in Anderson-Fabry disease // Lancet. - 2003; 361: 269-356.
  6. Chang L., Lee O., Naliboff B. et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome // Am. J. Gastroenterol. - 2001; 96: 3341-7.
  7. Chumpitazi B., Shulman R. Dietary Carbohydrates and Childhood Functional Abdominal Pain // Ann. Nutr. Metab. - 2016; 68 (l): 8-17.
  8. Di Stefano M., Miceli E., Gotti S. et al. The Effect of Oral а-Galactosidase on Intestinal Gas Production and Gas Related Symptoms // Dig. Dis. Sci. - 2007; 52 (1): 78-83.
  9. Giovanni Di Nardo, Salvatore Oliva, Federica Ferrari et al. Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children. A randomized, double-blind, plactbo-controlled trial // BMC Gastroenterology. -2013; 13: 142.
  10. Hernando-Harder A., Serra J., Azpiroz F. et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating // Am. J. Gastroenterol. -2010; 10: 876-82.
  11. Hillila M., Fakkila M., Sipponen T. et al. Does oral alpha-galactosidase relieve irritable bowel symptoms? // Scand. J. Gastroenterol. - 2016; 51 (1): 16-21.
  12. Houghton L., Whorwell P. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders // Neurogastroenterol. Motil. - 2005; 17: 500-11.
  13. Lin H. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome // JAMA. - 2004; 292: 852-8.
  14. Oh J., Lee J., Park H. et al. Аlpha-Galactosidase activity in human saliva // Arch. Oral Biol. - 2008; 53 (9): 842-8.
  15. Sandler R., Stewart W., Liberman J. et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact // Dig. Dis. Sci. - 2000; 45: 1166-71.
  16. Serra J., Azpiroz F., Malagelada J. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome // Gut. - 2001; 48: 14-9.
  17. Viana P., deRezende S., Falkoski D. et al. Hydrolysis of oligosaccharides in soybean products by Debaryomyces hansenii UFV1 а-galactosidases // Food Chemistry. - 2007; 103 (2): 331-7.
  18. Zar S., Benson M., Kumar D. Review article: bloating in functional bowel disorders // Aliment. Pharmacol. Ther. - 2002; 16: 1867-76.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies